MedTrace Logo

An Open-Label Trial of Repetitive Transcranial Magnetic Stimulation for Opioid Use Disorder

NCT04157062 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2025-04-10

No results posted yet for this study

Summary

The purpose of this study is to understand the role of repetitive Transcranial Magnetic Stimulation (rTMS) in reducing opioid and other substance use and craving and improving thinking skills.

Conditions

  • Opioid-use Disorder
  • Substance-Related Disorders
  • Chemically-Induced Disorders
  • Mental Disorder

Interventions

DEVICE

Repetitive Transcranial Magnetic Stimulation (rTMS)

During the rTMS session, an electromagnetic coil is placed against the subjects scalp. The electromagnet painlessly delivers a magnetic pulse that stimulates nerve cells in the region of the brain involved in memory and thinking.

Sponsors & Collaborators

  • West Virginia University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-30
Primary Completion
2025-03-19
Completion
2025-03-19
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04157062 on ClinicalTrials.gov